▶ 調査レポート

世界のOTC医薬品・栄養補助食品市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global OTC Drug and Dietary Supplement Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のOTC医薬品・栄養補助食品市場 2021:企業別、地域別、種類・用途別 / Global OTC Drug and Dietary Supplement Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-107A15050資料のイメージです。• レポートコード:GIR-107A15050
• 出版社/出版日:GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、91ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、OTC医薬品・栄養補助食品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。OTC医薬品・栄養補助食品の種類別市場規模(錠剤、粉末、カプセル、液体)、用途別市場規模(コンビニエンスストア、薬局、スーパーマーケット)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・OTC医薬品・栄養補助食品の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Pfizer、Amway、Suntory、Glanbia、GSK、Abbott、Herbalife、Reckitt Benckiser、Bayer、Blackmores
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:錠剤、粉末、カプセル、液体
・用途別分析2016年-2026年:コンビニエンスストア、薬局、スーパーマーケット
・OTC医薬品・栄養補助食品の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・OTC医薬品・栄養補助食品のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・OTC医薬品・栄養補助食品のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・OTC医薬品・栄養補助食品の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・OTC医薬品・栄養補助食品の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The OTC Drug and Dietary Supplement market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global OTC Drug and Dietary Supplement size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global OTC Drug and Dietary Supplement market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
OTC Drug and Dietary Supplement market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Tablets
Powders
Capsules
Liquids

Market segment by Application, can be divided into
Convenience Stores
Pharmacies
Supermarkets

Market segment by players, this report covers
Pfizer
Amway
Suntory
Glanbia
GSK
Abbott
Herbalife
Reckitt Benckiser
Bayer
Blackmores

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe OTC Drug and Dietary Supplement product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of OTC Drug and Dietary Supplement, with revenue, gross margin and global market share of OTC Drug and Dietary Supplement from 2019 to 2021.
Chapter 3, the OTC Drug and Dietary Supplement competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and OTC Drug and Dietary Supplement market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe OTC Drug and Dietary Supplement research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of OTC Drug and Dietary Supplement
1.2 Classification of OTC Drug and Dietary Supplement by Type
1.2.1 Overview: Global OTC Drug and Dietary Supplement Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global OTC Drug and Dietary Supplement Revenue Market Share by Type in 2020
1.2.3 Tablets
1.2.4 Powders
1.2.5 Capsules
1.2.6 Liquids
1.3 Global OTC Drug and Dietary Supplement Market by Application
1.3.1 Overview: Global OTC Drug and Dietary Supplement Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Convenience Stores
1.3.3 Pharmacies
1.3.4 Supermarkets
1.4 Global OTC Drug and Dietary Supplement Market Size & Forecast
1.5 Global OTC Drug and Dietary Supplement Market Size and Forecast by Region
1.5.1 Global OTC Drug and Dietary Supplement Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global OTC Drug and Dietary Supplement Market Size by Region, (2016-2021)
1.5.3 North America OTC Drug and Dietary Supplement Market Size and Prospect (2016-2026)
1.5.4 Europe OTC Drug and Dietary Supplement Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific OTC Drug and Dietary Supplement Market Size and Prospect (2016-2026)
1.5.6 South America OTC Drug and Dietary Supplement Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa OTC Drug and Dietary Supplement Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 OTC Drug and Dietary Supplement Market Drivers
1.6.2 OTC Drug and Dietary Supplement Market Restraints
1.6.3 OTC Drug and Dietary Supplement Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer OTC Drug and Dietary Supplement Product and Solutions
2.1.4 Pfizer OTC Drug and Dietary Supplement Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Amway
2.2.1 Amway Details
2.2.2 Amway Major Business
2.2.3 Amway OTC Drug and Dietary Supplement Product and Solutions
2.2.4 Amway OTC Drug and Dietary Supplement Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Amway Recent Developments and Future Plans
2.3 Suntory
2.3.1 Suntory Details
2.3.2 Suntory Major Business
2.3.3 Suntory OTC Drug and Dietary Supplement Product and Solutions
2.3.4 Suntory OTC Drug and Dietary Supplement Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Suntory Recent Developments and Future Plans
2.4 Glanbia
2.4.1 Glanbia Details
2.4.2 Glanbia Major Business
2.4.3 Glanbia OTC Drug and Dietary Supplement Product and Solutions
2.4.4 Glanbia OTC Drug and Dietary Supplement Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Glanbia Recent Developments and Future Plans
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business
2.5.3 GSK OTC Drug and Dietary Supplement Product and Solutions
2.5.4 GSK OTC Drug and Dietary Supplement Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 GSK Recent Developments and Future Plans
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott OTC Drug and Dietary Supplement Product and Solutions
2.6.4 Abbott OTC Drug and Dietary Supplement Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Abbott Recent Developments and Future Plans
2.7 Herbalife
2.7.1 Herbalife Details
2.7.2 Herbalife Major Business
2.7.3 Herbalife OTC Drug and Dietary Supplement Product and Solutions
2.7.4 Herbalife OTC Drug and Dietary Supplement Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Herbalife Recent Developments and Future Plans
2.8 Reckitt Benckiser
2.8.1 Reckitt Benckiser Details
2.8.2 Reckitt Benckiser Major Business
2.8.3 Reckitt Benckiser OTC Drug and Dietary Supplement Product and Solutions
2.8.4 Reckitt Benckiser OTC Drug and Dietary Supplement Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Reckitt Benckiser Recent Developments and Future Plans
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer OTC Drug and Dietary Supplement Product and Solutions
2.9.4 Bayer OTC Drug and Dietary Supplement Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Bayer Recent Developments and Future Plans
2.10 Blackmores
2.10.1 Blackmores Details
2.10.2 Blackmores Major Business
2.10.3 Blackmores OTC Drug and Dietary Supplement Product and Solutions
2.10.4 Blackmores OTC Drug and Dietary Supplement Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Blackmores Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global OTC Drug and Dietary Supplement Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 OTC Drug and Dietary Supplement Players Market Share
3.2.2 Top 10 OTC Drug and Dietary Supplement Players Market Share
3.2.3 Market Competition Trend
3.3 OTC Drug and Dietary Supplement Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global OTC Drug and Dietary Supplement Revenue and Market Share by Type (2016-2021)
4.2 Global OTC Drug and Dietary Supplement Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global OTC Drug and Dietary Supplement Revenue Market Share by Application (2016-2021)
5.2 OTC Drug and Dietary Supplement Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America OTC Drug and Dietary Supplement Revenue by Type (2016-2026)
6.2 North America OTC Drug and Dietary Supplement Revenue by Application (2016-2026)
6.3 North America OTC Drug and Dietary Supplement Market Size by Country
6.3.1 North America OTC Drug and Dietary Supplement Revenue by Country (2016-2026)
6.3.2 United States OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
6.3.3 Canada OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
6.3.4 Mexico OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe OTC Drug and Dietary Supplement Revenue by Type (2016-2026)
7.2 Europe OTC Drug and Dietary Supplement Revenue by Application (2016-2026)
7.3 Europe OTC Drug and Dietary Supplement Market Size by Country
7.3.1 Europe OTC Drug and Dietary Supplement Revenue by Country (2016-2026)
7.3.2 Germany OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
7.3.3 France OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
7.3.4 United Kingdom OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
7.3.5 Russia OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
7.3.6 Italy OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific OTC Drug and Dietary Supplement Revenue by Type (2016-2026)
8.2 Asia-Pacific OTC Drug and Dietary Supplement Revenue by Application (2016-2026)
8.3 Asia-Pacific OTC Drug and Dietary Supplement Market Size by Region
8.3.1 Asia-Pacific OTC Drug and Dietary Supplement Revenue by Region (2016-2026)
8.3.2 China OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
8.3.3 Japan OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
8.3.4 South Korea OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
8.3.5 India OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
8.3.7 Australia OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America OTC Drug and Dietary Supplement Revenue by Type (2016-2026)
9.2 South America OTC Drug and Dietary Supplement Revenue by Application (2016-2026)
9.3 South America OTC Drug and Dietary Supplement Market Size by Country
9.3.1 South America OTC Drug and Dietary Supplement Revenue by Country (2016-2026)
9.3.2 Brazil OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
9.3.3 Argentina OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa OTC Drug and Dietary Supplement Revenue by Type (2016-2026)
10.2 Middle East & Africa OTC Drug and Dietary Supplement Revenue by Application (2016-2026)
10.3 Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country
10.3.1 Middle East & Africa OTC Drug and Dietary Supplement Revenue by Country (2016-2026)
10.3.2 Turkey OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
10.3.4 UAE OTC Drug and Dietary Supplement Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global OTC Drug and Dietary Supplement Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global OTC Drug and Dietary Supplement Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market OTC Drug and Dietary Supplement Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global OTC Drug and Dietary Supplement Revenue (USD Million) by Region (2016-2021)
Table 5. Global OTC Drug and Dietary Supplement Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer OTC Drug and Dietary Supplement Product and Solutions
Table 9. Pfizer OTC Drug and Dietary Supplement Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Amway Corporate Information, Head Office, and Major Competitors
Table 11. Amway Major Business
Table 12. Amway OTC Drug and Dietary Supplement Product and Solutions
Table 13. Amway OTC Drug and Dietary Supplement Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Suntory Corporate Information, Head Office, and Major Competitors
Table 15. Suntory Major Business
Table 16. Suntory OTC Drug and Dietary Supplement Product and Solutions
Table 17. Suntory OTC Drug and Dietary Supplement Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Glanbia Corporate Information, Head Office, and Major Competitors
Table 19. Glanbia Major Business
Table 20. Glanbia OTC Drug and Dietary Supplement Product and Solutions
Table 21. Glanbia OTC Drug and Dietary Supplement Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. GSK Corporate Information, Head Office, and Major Competitors
Table 23. GSK Major Business
Table 24. GSK OTC Drug and Dietary Supplement Product and Solutions
Table 25. GSK OTC Drug and Dietary Supplement Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Abbott Corporate Information, Head Office, and Major Competitors
Table 27. Abbott Major Business
Table 28. Abbott OTC Drug and Dietary Supplement Product and Solutions
Table 29. Abbott OTC Drug and Dietary Supplement Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Herbalife Corporate Information, Head Office, and Major Competitors
Table 31. Herbalife Major Business
Table 32. Herbalife OTC Drug and Dietary Supplement Product and Solutions
Table 33. Herbalife OTC Drug and Dietary Supplement Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Reckitt Benckiser Corporate Information, Head Office, and Major Competitors
Table 35. Reckitt Benckiser Major Business
Table 36. Reckitt Benckiser OTC Drug and Dietary Supplement Product and Solutions
Table 37. Reckitt Benckiser OTC Drug and Dietary Supplement Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Bayer Corporate Information, Head Office, and Major Competitors
Table 39. Bayer Major Business
Table 40. Bayer OTC Drug and Dietary Supplement Product and Solutions
Table 41. Bayer OTC Drug and Dietary Supplement Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Blackmores Corporate Information, Head Office, and Major Competitors
Table 43. Blackmores Major Business
Table 44. Blackmores OTC Drug and Dietary Supplement Product and Solutions
Table 45. Blackmores OTC Drug and Dietary Supplement Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global OTC Drug and Dietary Supplement Revenue (USD Million) by Players (2019-2021)
Table 47. Global OTC Drug and Dietary Supplement Revenue Share by Players (2019-2021)
Table 48. Breakdown of OTC Drug and Dietary Supplement by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. OTC Drug and Dietary Supplement Players Head Office, Products and Services Provided
Table 50. OTC Drug and Dietary Supplement Mergers & Acquisitions in the Past Five Years
Table 51. OTC Drug and Dietary Supplement New Entrants and Expansion Plans
Table 52. Global OTC Drug and Dietary Supplement Revenue (USD Million) by Type (2016-2021)
Table 53. Global OTC Drug and Dietary Supplement Revenue Share by Type (2016-2021)
Table 54. Global OTC Drug and Dietary Supplement Revenue Forecast by Type (2021-2026)
Table 55. Global OTC Drug and Dietary Supplement Revenue by Application (2016-2021)
Table 56. Global OTC Drug and Dietary Supplement Revenue Forecast by Application (2021-2026)
Table 57. North America OTC Drug and Dietary Supplement Revenue by Type (2016-2021) & (USD Million)
Table 58. North America OTC Drug and Dietary Supplement Revenue by Type (2021-2026) & (USD Million)
Table 59. North America OTC Drug and Dietary Supplement Revenue by Application (2016-2021) & (USD Million)
Table 60. North America OTC Drug and Dietary Supplement Revenue by Application (2021-2026) & (USD Million)
Table 61. North America OTC Drug and Dietary Supplement Revenue by Country (2016-2021) & (USD Million)
Table 62. North America OTC Drug and Dietary Supplement Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe OTC Drug and Dietary Supplement Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe OTC Drug and Dietary Supplement Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe OTC Drug and Dietary Supplement Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe OTC Drug and Dietary Supplement Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe OTC Drug and Dietary Supplement Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe OTC Drug and Dietary Supplement Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific OTC Drug and Dietary Supplement Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific OTC Drug and Dietary Supplement Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific OTC Drug and Dietary Supplement Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific OTC Drug and Dietary Supplement Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific OTC Drug and Dietary Supplement Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific OTC Drug and Dietary Supplement Revenue by Region (2021-2026) & (USD Million)
Table 75. South America OTC Drug and Dietary Supplement Revenue by Type (2016-2021) & (USD Million)
Table 76. South America OTC Drug and Dietary Supplement Revenue by Type (2021-2026) & (USD Million)
Table 77. South America OTC Drug and Dietary Supplement Revenue by Application (2016-2021) & (USD Million)
Table 78. South America OTC Drug and Dietary Supplement Revenue by Application (2021-2026) & (USD Million)
Table 79. South America OTC Drug and Dietary Supplement Revenue by Country (2016-2021) & (USD Million)
Table 80. South America OTC Drug and Dietary Supplement Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa OTC Drug and Dietary Supplement Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa OTC Drug and Dietary Supplement Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa OTC Drug and Dietary Supplement Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa OTC Drug and Dietary Supplement Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa OTC Drug and Dietary Supplement Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa OTC Drug and Dietary Supplement Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. OTC Drug and Dietary Supplement Picture
Figure 2. Global OTC Drug and Dietary Supplement Revenue Market Share by Type in 2020
Figure 3. Tablets
Figure 4. Powders
Figure 5. Capsules
Figure 6. Liquids
Figure 7. OTC Drug and Dietary Supplement Revenue Market Share by Application in 2020
Figure 8. Convenience Stores Picture
Figure 9. Pharmacies Picture
Figure 10. Supermarkets Picture
Figure 11. Global OTC Drug and Dietary Supplement Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global OTC Drug and Dietary Supplement Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global OTC Drug and Dietary Supplement Revenue Market Share by Region (2016-2026)
Figure 14. Global OTC Drug and Dietary Supplement Revenue Market Share by Region in 2020
Figure 15. North America OTC Drug and Dietary Supplement Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe OTC Drug and Dietary Supplement Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific OTC Drug and Dietary Supplement Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America OTC Drug and Dietary Supplement Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa OTC Drug and Dietary Supplement Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. OTC Drug and Dietary Supplement Market Drivers
Figure 21. OTC Drug and Dietary Supplement Market Restraints
Figure 22. OTC Drug and Dietary Supplement Market Trends
Figure 23. Pfizer Recent Developments and Future Plans
Figure 24. Amway Recent Developments and Future Plans
Figure 25. Suntory Recent Developments and Future Plans
Figure 26. Glanbia Recent Developments and Future Plans
Figure 27. GSK Recent Developments and Future Plans
Figure 28. Abbott Recent Developments and Future Plans
Figure 29. Herbalife Recent Developments and Future Plans
Figure 30. Reckitt Benckiser Recent Developments and Future Plans
Figure 31. Bayer Recent Developments and Future Plans
Figure 32. Blackmores Recent Developments and Future Plans
Figure 33. Global OTC Drug and Dietary Supplement Revenue Share by Players in 2020
Figure 34. OTC Drug and Dietary Supplement Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players OTC Drug and Dietary Supplement Revenue Market Share in 2020
Figure 36. Global Top 10 Players OTC Drug and Dietary Supplement Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global OTC Drug and Dietary Supplement Revenue Share by Type in 2020
Figure 39. Global OTC Drug and Dietary Supplement Market Share Forecast by Type (2021-2026)
Figure 40. Global OTC Drug and Dietary Supplement Revenue Share by Application in 2020
Figure 41. Global OTC Drug and Dietary Supplement Market Share Forecast by Application (2021-2026)
Figure 42. North America OTC Drug and Dietary Supplement Sales Market Share by Type (2016-2026)
Figure 43. North America OTC Drug and Dietary Supplement Sales Market Share by Application (2016-2026)
Figure 44. North America OTC Drug and Dietary Supplement Revenue Market Share by Country (2016-2026)
Figure 45. United States OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe OTC Drug and Dietary Supplement Sales Market Share by Type (2016-2026)
Figure 49. Europe OTC Drug and Dietary Supplement Sales Market Share by Application (2016-2026)
Figure 50. Europe OTC Drug and Dietary Supplement Revenue Market Share by Country (2016-2026)
Figure 51. Germany OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific OTC Drug and Dietary Supplement Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific OTC Drug and Dietary Supplement Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific OTC Drug and Dietary Supplement Revenue Market Share by Region (2016-2026)
Figure 59. China OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America OTC Drug and Dietary Supplement Sales Market Share by Type (2016-2026)
Figure 66. South America OTC Drug and Dietary Supplement Sales Market Share by Application (2016-2026)
Figure 67. South America OTC Drug and Dietary Supplement Revenue Market Share by Country (2016-2026)
Figure 68. Brazil OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa OTC Drug and Dietary Supplement Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa OTC Drug and Dietary Supplement Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa OTC Drug and Dietary Supplement Revenue Market Share by Country (2016-2026)
Figure 73. Turkey OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE OTC Drug and Dietary Supplement Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source